241 related articles for article (PubMed ID: 33266317)
1. Suppression of Ovarian Cancer Cell Growth by AT-MSC Microvesicles.
Szyposzynska A; Bielawska-Pohl A; Krawczenko A; Doszyn O; Paprocka M; Klimczak A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266317
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary Ovarian Cancer Cells and Their Therapeutic Opportunities.
Szyposzynska A; Bielawska-Pohl A; Murawski M; Sozanski R; Chodaczek G; Klimczak A
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958844
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
[TBL] [Abstract][Full Text] [Related]
4. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
[TBL] [Abstract][Full Text] [Related]
5. Effect of human bone marrow mesenchymal stem cell-derived microvesicles on the apoptosis of the multiple myeloma cell line U266.
Vafaeizadeh M; Abroun S; Soufi Zomorrod M
J Cancer Res Clin Oncol; 2024 Jun; 150(6):299. PubMed ID: 38850382
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral potential of microvesicles extracted from human adipose-derived mesenchymal stem cells on human breast cancer cells.
Rezaie Z; Ardeshirylajimi A; Ashkezari MD; Seifati SM
J Cancer Res Ther; 2019; 15(5):1114-1119. PubMed ID: 31603120
[TBL] [Abstract][Full Text] [Related]
7. Static magnetic field enhances synthesis and secretion of membrane-derived microvesicles (MVs) rich in VEGF and BMP-2 in equine adipose-derived stromal cells (EqASCs)-a new approach in veterinary regenerative medicine.
Marędziak M; Marycz K; Lewandowski D; Siudzińska A; Śmieszek A
In Vitro Cell Dev Biol Anim; 2015 Mar; 51(3):230-40. PubMed ID: 25428200
[TBL] [Abstract][Full Text] [Related]
8. HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds-In Vitro Study.
Kraskiewicz H; Hinc P; Krawczenko A; Bielawska-Pohl A; Paprocka M; Witkowska D; Mohd Isa IL; Pandit A; Klimczak A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830121
[TBL] [Abstract][Full Text] [Related]
9. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
Khalil C; Moussa M; Azar A; Tawk J; Habbouche J; Salameh R; Ibrahim A; Alaaeddine N
J Ovarian Res; 2019 Jul; 12(1):70. PubMed ID: 31351482
[TBL] [Abstract][Full Text] [Related]
11. The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases.
Chen J; Li C; Chen L
Biomed Res Int; 2015; 2015():985814. PubMed ID: 26064975
[TBL] [Abstract][Full Text] [Related]
12. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.
Bruno S; Grange C; Collino F; Deregibus MC; Cantaluppi V; Biancone L; Tetta C; Camussi G
PLoS One; 2012; 7(3):e33115. PubMed ID: 22431999
[TBL] [Abstract][Full Text] [Related]
13. Microvesicles derived from human bone marrow mesenchymal stem cells promote U2OS cell growth under hypoxia: the role of PI3K/AKT and HIF-1α.
Lin S; Zhu B; Huang G; Zeng Q; Wang C
Hum Cell; 2019 Jan; 32(1):64-74. PubMed ID: 30506278
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice.
Yang Z; Du X; Wang C; Zhang J; Liu C; Li Y; Jiang H
Stem Cell Res Ther; 2019 Aug; 10(1):250. PubMed ID: 31412919
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells microvesicles stabilize endothelial barrier function partly mediated by hepatocyte growth factor (HGF).
Wang H; Zheng R; Chen Q; Shao J; Yu J; Hu S
Stem Cell Res Ther; 2017 Sep; 8(1):211. PubMed ID: 28969681
[TBL] [Abstract][Full Text] [Related]
16. Microvesicles of osteoblasts modulate bone marrow mesenchymal stem cell-induced apoptosis to curcumin in myeloid leukemia cells.
Zahedpanah M; Takanlu JS; Nikbakht M; Rad F; Farhid F; Mousavi SA; Rad S; Fumani HK; Hosseini Rad SMA; Mohammadi S
J Cell Physiol; 2019 Aug; 234(10):18707-18719. PubMed ID: 30916405
[TBL] [Abstract][Full Text] [Related]
17. Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth.
Bruno S; Collino F; Deregibus MC; Grange C; Tetta C; Camussi G
Stem Cells Dev; 2013 Mar; 22(5):758-71. PubMed ID: 23034046
[TBL] [Abstract][Full Text] [Related]
18. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
Wang Y; Lu X; He J; Zhao W
Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
[TBL] [Abstract][Full Text] [Related]
19. The effect of simultaneous administration of arsenic trioxide and microvesicles derived from human bone marrow mesenchymal stem cells on cell proliferation and apoptosis of acute myeloid leukemia cell line.
Abbaszade Dibavar M; Soleimani M; Atashi A; Rassaei N; Amiri S
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S138-S146. PubMed ID: 30600718
[TBL] [Abstract][Full Text] [Related]
20. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells.
Reza AMMT; Choi YJ; Yasuda H; Kim JH
Sci Rep; 2016 Dec; 6():38498. PubMed ID: 27929108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
